OHRE Pharma drugs

In compliance with art L.5121-1-3 of French Public Health Code, please find hereunder the list of medicinal product for which OHRE Pharma is responsable for placing on the market :

  • Ambrisentan OHRE Pharma 5 mg, tablet – SPC 05/03/2020
  • Ambrisentan OHRE Phama 10 mg, tablet – SPC 05/03/2020
  • Bortézomib OHRE Pharma 1 mg, powder for solution for injection – SPC 12/09/2019
  • Bortézomib OHRE Pharma 3,5 mg, powder for solution for injection – SPC 12/09/219
  • Bosentan OHRE Pharma 62,5 mg, tablet – SPC 26/01/2018
  • Bosentan OHRE Pharma 125 mg, tablet – SPC 26/01/2018
  • Caspofungin OHRE Pharma 50 mg, powder for concentrate for solution for infusion – SPC 04/09/2020
  • Caspofungin OHRE Pharma 70 mg, powder for concentrate for solution for infusion – SPC 04/09/2020
  • Linezolid OHRE Pharma 600 mg, tablet – SPC 12/09/2019
  • Mémantine OHRE Pharma 10 mg/ml, oral solution – SPC 05/05/2020
  • Micafungin OHRE Pharma 50 mg, powder for concentrate for solution for infusion – SPC 27/07/2020
  • Micafungin OHRE Pharma 100 mg, powder for concentrate for solution for infusion – SPC 27/07/2020
  • Posaconazole OHRE Pharma 40 mg/ml, oral suspension – SPC 16/03/2020
  • Sildénafil OHRE Pharma 20 mg, tablet – SPC 09/02/2018
  • Voriconazole OHRE Pharma 50 mg, tablet – SPC 20/04/2020
  • Voriconazole OHRE Pharma 200 mg, tablet – SPC 20/04/2020
  • Voriconazole OHRE Pharma 200 mg, powder for solution for injection – SPC 11/06/2020

For more information concerning our drugs, you can click to the following link: French medicinal product data base.

As part of our Risk Management Plan, for some of our drugs, OHRE Pharma laboratory provide additional risk minimization brochures (validated by the French National  Medicines Agency) to patients and healthcare professionals:

For Bosentan OHRE Pharma:

For Voriconazole OHRE Pharma:

  • Patient brochure focusing on the most important information in order to guarantee voriconazole safe use
    • To see or download this booklet follow this link.
  • Healthcare professional brochure with questions /answers and chek-list.
    • To see and download the HCP brochure, click on this link.
    • To see and download the checklist, click on this link.

For Ambrisentan OHRE Pharma:

  • patient brochure to provide to patient before the first prescription of the drug.

For Micafungin OHRE Pharma:

  • Check list to provide to doctors before the first prescription of the drug.

Last update realized in February 2021.